Results for tag: "Polynucleotides Injectable"

Polynucleotides injectables are a class of pharmaceuticals used for various therapeutic applications, administered through infusion or injection into the body. They consist of long chains of nucleotides which are the basic building blocks of DNA and RNA. These injectables are designed to replicate, modulate, or interfere with natural biological processes for the treatment of a variety of medical conditions, such as genetic disorders, cancers, and viral infections. They can be administered intravenously, subcutaneously, or intramuscularly, depending on the treatment regimen. The market for polynucleotides injectables falls within the broader category of infusions and injectables, which encompasses a range of drugs and therapies delivered directly into the bloodstream or tissue to ensure precise dosing and immediate drug effect. Some well-known pharmaceutical and biotech companies involved in the development and commercialization of polynucleotides injectables include Pfizer, Moderna Therapeutics, Alnylam Pharmaceuticals, and Ionis Pharmaceuticals. These companies have been pioneers in advancing the research, development, and delivery of polynucleotide-based therapies, focusing on innovative solutions for previously untreatable or difficult-to-manage conditions. Show Less Read more